Madrigal Pharmaceuticals
MDGL
#2088
Rank
ยฃ6.73 B
Marketcap
ยฃ289.79
Share price
-4.45%
Change (1 day)
-30.75%
Change (1 year)

EPS for Madrigal Pharmaceuticals (MDGL)

EPS in 2026 (TTM): -ยฃ4.43

According to Madrigal Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ4.52. In 2025 the company made an earnings per share (EPS) of -ยฃ8.17 an increase over its 2024 EPS that were of -ยฃ16.90.

EPS history for Madrigal Pharmaceuticals from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ4.43-45.77%
2025-ยฃ8.17-51.65%
2024-ยฃ16.90
2022-ยฃ13.1717.93%
2021-ยฃ11.1711.61%
2020-ยฃ10.01140.18%
2019-ยฃ4.17146.61%
2018-ยฃ1.69-12.99%
2017-ยฃ1.94-91.03%
2016-ยฃ21.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-ยฃ0.15-96.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ0.73-83.93%๐Ÿ‡บ๐Ÿ‡ธ USA